An open-label, single-dose, non-randomized, 4-period crossover bioavailability study of bazedoxifene contained in bazedoxifene/conjugated estrogen tablets administered to healthy postmenopausal women
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2007
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Pfizer
- 04 Dec 2007 Status changed from initiated to completed.
- 16 Nov 2007 New trial record.